about
Using meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results - a case studyAdapting a Markov Monte Carlo simulation model for forecasting the number of coronary artery revascularisation procedures in an era of rapidly changing technology and policy.A review of health utilities using the EQ-5D in studies of cardiovascular disease.The disutility of restenosis--the impact of repeat percutaneous coronary intervention on quality of life.Economic evaluation of increasing population rates of cardiac catheterizationCanadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies.Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework.Effect of hospital ownership status and payment structure on the adoption and use of drug-eluting stents for percutaneous coronary interventionsIndications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®.Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarctionTreatment variation in stent choice in patients with stable or unstable coronary artery diseaseThe cost-effectiveness of drug-eluting stents: a systematic review.The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review.Medical technology as a key driver of rising health expenditure: disentangling the relationshipEconomic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis.Potential shift from coronary bypass surgery to percutaneous coronary intervention for multivessel disease and its economic impact in the drug-eluting stent era.The cost-effectiveness of strategies in coronary artery disease.MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS.Contemporary Context of Drug-Eluting Stents in Brazil: A Cost Utility Study.The dollars and sense of drug-eluting stentsUnderstanding the economic impact of intravascular ultrasound (IVUS).Are drug eluting stents really worth the money?Resource allocation among cardiovascular specialists and trainees: a pilot survey.Medical therapy v. PCI in stable coronary artery disease: a cost-effectiveness analysis.Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial.Cost-effectiveness of drug-eluting stents: real-world scrutiny of the BASKET trial of real-world usage.
P2860
Q28066022-E2B199EE-A9AF-4731-BB4E-F67F5A0A23E7Q33346623-596EBF68-E53D-48C0-9F64-0BDE3520ACD5Q33669647-EEAAA6BB-60D7-4BF4-A4E4-0A81BB9DC6ABQ33994074-C8E62346-5D70-4B0C-9F50-401A4E352423Q34083264-3438D8EA-D3D3-4A39-8F32-D358EF188A86Q34157292-3817785D-8B5C-4814-8B35-E719C039DC85Q34625565-3433FEDA-521B-455F-B735-8AF9F21CFC41Q35575044-E4ED1B56-CA9C-4707-B6EB-E61184442DEDQ35740635-5CA427C7-D3D5-4CD8-B789-67B94242423DQ36469832-D624A4FD-D1D6-439B-BD20-769BA23FB237Q36488131-D636E255-604C-41DF-8ED0-705CD68FF8CDQ36688107-D6B66EEA-4A30-4427-987F-FA9353DCC243Q36735675-41964B2B-C021-4A66-837F-AABA1616B875Q36939686-66ACD026-AAC4-4324-A47F-0214A47ED129Q36972090-95B8F86F-8AE3-474D-B3E5-DE5E5B83D971Q37119212-30E5E20F-6A1F-4DE6-BC03-6ACA48487117Q38255595-C2DDCE99-234A-494C-B477-A2842A9760A0Q38491781-1D484905-3095-4E4C-AE6A-0512DE6E84BCQ39930957-B4F4DBF3-9C14-4813-91C9-0C6EA4B782A5Q40948215-D37C9B19-08F1-47F8-A7E5-C64B45671977Q41452487-5054C876-1D84-4E72-BCCA-870CB6CA6A76Q42831565-3A88C13B-34A2-4FA8-877A-49430D5F168CQ43178922-11D89A1D-A947-40C5-9BC8-0E17F6BD5540Q43705921-1D69B9E6-94C1-46A8-B17C-F1F3A91C099BQ45846827-8295D691-151E-4D76-B74A-096F7090EAB2Q45988138-9D9DBED3-5514-458C-8E87-E68D940CE0A8Q51179501-2DBB8344-37E5-4B0D-8D11-2DBFDE81645AQ51218094-4640BE20-2C9F-4D72-825F-618A717C1302
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Economic evaluation of sirolimus-eluting stents.
@ast
Economic evaluation of sirolimus-eluting stents.
@en
type
label
Economic evaluation of sirolimus-eluting stents.
@ast
Economic evaluation of sirolimus-eluting stents.
@en
prefLabel
Economic evaluation of sirolimus-eluting stents.
@ast
Economic evaluation of sirolimus-eluting stents.
@en
P2093
P2860
P356
P1476
Economic evaluation of sirolimus-eluting stents.
@en
P2093
APPROACH Investigators
Braden J Manns
Fiona M Shrive
Merril L Knudtson
P Diane Galbraith
William A Ghali
P2860
P304
P356
10.1503/CMAJ.1041062
P407
P577
2005-02-01T00:00:00Z